Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Non-Current Debt (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Non-Current Debt for 8 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 6.65% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 6.65% increase, with the full-year FY2025 number at $1.8 billion, up 6.65% from a year prior.
  • Non-Current Debt was $1.8 billion for Q4 2025 at Select Medical Holdings, up from $1.7 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $3.8 billion in Q4 2022 to a low of $1.7 billion in Q4 2024.
  • A 5-year average of $3.1 billion and a median of $3.6 billion in 2021 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: grew 10.82% in 2022, then crashed 52.98% in 2025.
  • Select Medical Holdings' Non-Current Debt stood at $3.6 billion in 2021, then rose by 7.84% to $3.8 billion in 2022, then fell by 6.54% to $3.6 billion in 2023, then tumbled by 52.81% to $1.7 billion in 2024, then increased by 6.65% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for SEM's Non-Current Debt are $1.8 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.8 billion (Q2 2025).